Modeling Tic Change During Behavior Therapy for Tics

Last updated: February 23, 2025
Sponsor: University of Minnesota
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tic Disorders

Tourette's Syndrome

Treatment

CBIT

Clinical Study ID

NCT06270251
PSYCH-2023-32292
  • Ages 12-21
  • All Genders

Study Summary

Chronic tics are a disabling neuropsychiatric symptom associated with multiple child-onset mental disorders. Chronic tics affect 1-3% of youth and can be associated with impaired functioning, emotional and behavioral problems, physical pain, diminished quality of life, and peer victimization. Chronic tics are the primary symptom of Tourette Syndrome (TS) and Persistent Motor/Vocal Tic Disorders.

CBIT is a manualized treatment focused on increasing tic controllability. Its core procedure is competing response training (CRT), in which patients learn to inhibit tics by learning and applying a competing motor action to one tic at a time. CBIT is recommended as a first-line treatment relative to medications and other therapies. However, only 52% of children and 38% of adults show clinically meaningful tic improvement. Large randomized trials have demonstrated the superiority of CBIT over supportive therapy in child and adult patients, and meta-analysis shows comparable effect sizes for CBIT and medication. Although increasing tic controllability is the primary goal of CBIT, tic controllability nor its correlates have been examined longitudinally during the intervention.

The overall objective of this study is to use fine-grained data collection strategies to identify patterns in tic controllability and other relevant related variables that are associated with treatment response to CBIT. Participants with chronic tics will complete a manualized course of 8-session CBIT. Behavioral, psychosocial, and global functioning will be assessed longitudinally to examine predictors and correlates of response. CBIT sessions will be video recorded.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 12-21 years at time of enrollment.

  • Current chronic motor and/or vocal tics, defined as tics for at least 1 year withouta tic-free period of more than 3 consecutive months. Tics must not be due to amedical condition or the direct physiological effects of a substance.

  • At least moderate tic severity, defined as a Yale Global Tic Severity Scale totalscore

≥14 (≥9 for those with motor or vocal tics only).

  • Full scale IQ greater than 70

  • English fluency to ensure comprehension of study measures and instructions.

Exclusion

Exclusion Criteria:

  • Active suicidality.

  • Previous diagnosis of psychosis or cognitive disability.

  • Substance abuse or dependence within the past year.

  • Concurrent psychotherapy focused on tics.

  • Neuroleptic/antipsychotic medications.

  • Taking a medication that has not reached stability criterion (same medication anddose for 6 weeks with no planned changes over the intervention period)

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: CBIT
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
September 01, 2028

Connect with a study center

  • University of Minnesota

    Minneapolis, Minnesota 55414
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.